Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.54 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.54 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.54 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL11789630 | 0.98 | MEN1 (0.67) | MEN1KMT2ALMNAMAPTNPC1 | |
| SCHEMBL10710090 | 0.85 | MEN1 (0.79) | MEN1KMT2ALMNAMAPTNPC1 | |
| SCHEMBL2094293 | 0.83 | MEN1 (0.69) | MEN1KMT2ALMNAMAPTNPC1 | |
| SCHEMBL9835974 | 0.83 | MEN1 (0.69) | MEN1KMT2ALMNAMAPTNPC1 | |
| SCHEMBL2097652 | 0.83 | CYP1A2 (0.62) | MEN1KMT2ALMNAMAPTNPC1 | |
| SCHEMBL18138901 | 0.82 | MAPT (0.51) | MEN1KMT2ALMNAMAPTNPC1 | |
| SCHEMBL3612815 | 0.82 | MEN1 (0.67) | MEN1KMT2ALMNAMAPTNPC1 | |
| SCHEMBL2008072 | 0.82 | MEN1 (1.00) | MEN1KMT2ALMNAMAPTNPC1 | |
| SCHEMBL2093177 | 0.82 | MAPT (0.71) | MEN1KMT2ALMNAMAPTHPGD | |
| SCHEMBL30623497 | 0.82 | MEN1 (0.67) | MEN1KMT2ALMNAMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12281104-B2 | Process for the production of ethyl 3-amino-1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]pyrazole-4-carboxylate through chiral separation of a racemic mixture | INTERVET INC. (US) | 2025-04-22 | — | — | US | disclosed |
| US-20220204483-A1 | Process for the Production of Ethyl 3-Amino-1-[(3R,4S)-4-Cyanotetrahydropyran-3-YL]pyrazole-4-Carboxylate Through Chiral Separation of a Racemic Mixture | INTERVET INC. (US) | 2022-06-30 | — | — | US | disclosed |
| EP-3991835-A1 | TRIGLYCERIDE ANALYSIS METHOD, OIL AND FAT SORTING METHOD, AND TRIGLYCERIDE PRODUCTION METHOD | The Nisshin OilliO Group, Ltd. (JP) | 2022-05-04 | — | — | EP | disclosed |
| WO-2019194127-A1 | METHOD FOR ANALYZING TRIGLYCERIDE, METHOD FOR SEPARATING OIL AND FAT, AND METHOD FOR MANUFACTURING TRIGLYCERIDE | 日清オイリオグループ株式会社 | 2019-10-10 | — | — | WO | disclosed |
| US-9149791-B2 | Water-soluble carbohydrate polyethers | TRGel, LLC (US) | 2015-10-06 | — | — | US | disclosed |
| US-8642502-B2 | Reversible gel-forming compositions for controlled delivery of bioactive substances | TRGel, LLC (US) | 2014-02-04 | — | — | US | disclosed |
| US-20130035310-A1 | Piperidine and Piperazine Phenyl Sulfonamides as Modulators of Ion Channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-02-07 | — | — | US | disclosed |
| US-20130035310-A1 | Piperidine and Piperazine Phenyl Sulfonamides as Modulators of Ion Channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-02-07 | — | — | US | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20120087891-A1 | Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances | GORKOVENKO ALEXANDER A (US) | 2012-04-12 | — | — | US | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| US-5489387-A | Separation agent comprising acyl- or carbamoyl-substituted polysaccharide | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1996-02-06 | — | — | US | disclosed |
| US-5415780-A | Separation agent comprising acyl- or carbamoyl-substituted polysaccharide | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-16 | — | — | US | disclosed |
| US-5368737-A | Resolution | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-29 | — | — | US | disclosed |
| US-5229002-A | Separation of optical isomers, cellulose esterified with phenylazobenzoic acid | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-20 | — | — | US | disclosed |
| US-5137638-A | Mixture of orticla isomers; cellulose tricinnamate | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1992-08-11 | — | — | US | disclosed |
| US-5075009-A | Optical resolution of racemic mixtures using a cellulose tris-4-biphenyl carboxylate | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-12-24 | — | — | US | disclosed |
| US-5017290-A | Chromatography | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| US-4966694-A | CELLULOSE TRI-BETA-NAPHTHOATE; OPTICAL RESOLUTIONS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1990-10-30 | — | — | US | disclosed |
| US-4879038-A | Separation agent comprising acyl- or carbamoyl-substituted polysaccharide | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1989-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281104-B2 | Process for the production of ethyl 3-amino-1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]pyrazole-4-carboxylate through chiral separation of a racemic mixture | CYP3A4, CYP4B1, ACMSD | MEN1 4729/4885KMT2A 3906/4885LMNA 4342/4885 |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | MEN1 4525/4885KMT2A 3324/4885LMNA 4594/4885 |
| US-20130035310-A1 | Piperidine and Piperazine Phenyl Sulfonamides as Modulators of Ion Channels | TRPV1, TRPV5, TRPA1 | MEN1 4701/4885KMT2A 1129/4885LMNA 4008/4885 |
| US-20120087891-A1 | Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances | PGF, CEL, F12 | MEN1 3074/4885KMT2A 4699/4885LMNA 1565/4885 |
| US-20220204483-A1 | Process for the Production of Ethyl 3-Amino-1-[(3R,4S)-4-Cyanotetrahydropyran-3-YL]pyrazole-4-Carboxylate Through Chiral Separation of a Racemic Mixture | CYP3A4, CYP4B1, ACMSD | MEN1 4729/4885KMT2A 3906/4885LMNA 4342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.